225 related articles for article (PubMed ID: 18467435)
41. Heat Stress Modulates Both Anabolic and Catabolic Signaling Pathways Preventing Dexamethasone-Induced Muscle Atrophy In Vitro.
Tsuchida W; Iwata M; Akimoto T; Matsuo S; Asai Y; Suzuki S
J Cell Physiol; 2017 Mar; 232(3):650-664. PubMed ID: 27649272
[TBL] [Abstract][Full Text] [Related]
42. Brain-derived Neurotrophic Factor Promotes Growth of Neurons and Neural Stem Cells Possibly by Triggering the Phosphoinositide 3-Kinase/ AKT/Glycogen Synthase Kinase-3β/β-catenin Pathway.
Li XT; Liang Z; Wang TT; Yang JW; Ma W; Deng SK; Wang XB; Dai YF; Guo JH; Li LY
CNS Neurol Disord Drug Targets; 2017; 16(7):828-836. PubMed ID: 28524001
[TBL] [Abstract][Full Text] [Related]
43. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
44. Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway.
Piracha ZZ; Kwon H; Saeed U; Kim J; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111572
[TBL] [Abstract][Full Text] [Related]
45. Salidroside Mitigates Sepsis-Induced Myocarditis in Rats by Regulating IGF-1/PI3K/Akt/GSK-3β Signaling.
He H; Chang X; Gao J; Zhu L; Miao M; Yan T
Inflammation; 2015 Dec; 38(6):2178-84. PubMed ID: 26104971
[TBL] [Abstract][Full Text] [Related]
46. Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.
Mannoury la Cour C; Salles MJ; Pasteau V; Millan MJ
Mol Pharmacol; 2011 Jan; 79(1):91-105. PubMed ID: 20952497
[TBL] [Abstract][Full Text] [Related]
47. Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3β/JNK signaling.
Wang L; Yang HJ; Xia YY; Feng ZW
Apoptosis; 2010 Dec; 15(12):1470-9. PubMed ID: 20963499
[TBL] [Abstract][Full Text] [Related]
48. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
Gilson H; Schakman O; Combaret L; Lause P; Grobet L; Attaix D; Ketelslegers JM; Thissen JP
Endocrinology; 2007 Jan; 148(1):452-60. PubMed ID: 17038559
[TBL] [Abstract][Full Text] [Related]
49. Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
Umeki D; Ohnuki Y; Mototani Y; Shiozawa K; Suita K; Fujita T; Nakamura Y; Saeki Y; Okumura S
PLoS One; 2015; 10(6):e0128263. PubMed ID: 26053620
[TBL] [Abstract][Full Text] [Related]
50. GSK-3β/CREB axis mediates IGF-1-induced ECM/adhesion molecule expression, cell cycle progression and monolayer permeability in retinal capillary endothelial cells: Implications for diabetic retinopathy.
Devi TS; Singh LP; Hosoya K; Terasaki T
Biochim Biophys Acta; 2011 Sep; 1812(9):1080-8. PubMed ID: 21549192
[TBL] [Abstract][Full Text] [Related]
51. Glucocorticoids differentially modulate insulin-mediated protein and glycogen synthetic signaling downstream of protein kinase B in rat myocardium.
Wu Y; Barrett EJ; Long W; Liu Z
Endocrinology; 2004 Mar; 145(3):1161-6. PubMed ID: 14630710
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
53. Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling.
Wang L; Shao YY; Ballock RT
J Bone Miner Res; 2010 May; 25(5):1138-46. PubMed ID: 20200966
[TBL] [Abstract][Full Text] [Related]
54. The effects of omega-3 fatty acid supplementation on dexamethasone-induced muscle atrophy.
Fappi A; Godoy TS; Maximino JR; Rizzato VR; Neves Jde C; Chadi G; Zanoteli E
Biomed Res Int; 2014; 2014():961438. PubMed ID: 24982916
[TBL] [Abstract][Full Text] [Related]
55. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
[TBL] [Abstract][Full Text] [Related]
56. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades.
Wada A
J Pharmacol Sci; 2009 May; 110(1):14-28. PubMed ID: 19423950
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
Lee J; Ju J; Park S; Hong SJ; Yoon S
Nutr Cancer; 2012; 64(1):153-62. PubMed ID: 22098108
[TBL] [Abstract][Full Text] [Related]
58. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Hardt SE; Tomita H; Katus HA; Sadoshima J
Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
[TBL] [Abstract][Full Text] [Related]
59. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.
Kalista S; Schakman O; Gilson H; Lause P; Demeulder B; Bertrand L; Pende M; Thissen JP
Endocrinology; 2012 Jan; 153(1):241-53. PubMed ID: 22087027
[TBL] [Abstract][Full Text] [Related]
60. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
